ORPHA:63443
Rare epithelial tumor of stomach
Synonyms: Rare gastric epithelial tumor
- Type
- Category
- Group
- Group of disorders
- Inheritance
- Multigenic/multifactorial, Not applicable
- Age of onset
- Adult
- Status
- active
This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Rare epithelial tumor of stomach | Rare gastric epithelial tumor |
| fr | Tumeur épithéliale rare de l'estomac | Tumeur épithéliale gastrique rare |
| de | Seltener epithelialer Tumor des Magens | |
| es | Tumor epitelial raro de estómago | Tumor epitelial gástrico raro |
| it | Tumore epiteliale raro dello stomaco | Tumore epiteliale gastrico raro |
| nl | Zeldzame epitheliale tumor van maag | Zeldzame epitheliale maagtumor |
| pt | Cancro gástrico | Cancro do estômago |
| pl | Rzadki nabłonkowy guz żołądka | = en |
| cs | Vzácný epiteliální tumor žaludku | Vzácný žaludeční epiteliální tumor |
| uk | Рідкісна епітеліальна пухлина шлунка | Рідкісна епітеліальна пухлина шлунка |
| zh | 罕见胃上皮性肿瘤 | 罕见胃上皮瘤 |
| tr | Nadir mide epitel tümörü | Nadir mide epitel tümörü |
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| MONDO | 18972 | E | validated | |
| UMLS | C5680118 | E | validated | |
| MedDRA | 10017758 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:180821Rare gastroesophageal tumor
rare gastroenterological diseases; rare neoplastic diseases
4
Genes
0 directOrphanet records no gene directly on this code.
5
Prevalence and incidence
7 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Annual incidence | 1-5 / 10 000 | 18.6 / 100 000 | Europe | Value and class | Validated | RARECARE surveillance of rare cancers in Europe[OTHER] |
| Lifetime Prevalence | 1-5 / 10 000 | 49.17 / 100 000 | Europe | Value and class | Validated | 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER] |
| Annual incidence | 1-9 / 100 000 | 7.5 / 100 000 | United States | Value and class | Validated | National Cancer OTHERitute 2010[OTHER] |
| Point prevalence | 1-5 / 10 000 | 24 / 100 000 | United States | Value and class | Validated | National Cancer OTHERitute 2010[OTHER] |
| Annual incidence | 1-5 / 10 000 | 11.2 / 100 000 | United Kingdom | Value and class | Validated | National Cancer Intelligence Network 2006[OTHER] |
| Point prevalence | 1-9 / 100 000 | 3.9 / 100 000 | United Kingdom | Value and class | Validated | National Cancer Intelligence Network 2006[OTHER] |
| Point prevalence | 1-9 / 100 000 | — | Europe | Class only | Validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/63443
- This record as JSON: /data/d/63443.json